These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8551064)

  • 61. Overexpression of proCOL11A1 as a stromal marker of breast cancer.
    Fuentes-Martínez N; García-Pravia C; García-Ocaña M; Menéndez-Rodríguez P; Del Amo J; Suárez-Fernández L; Galván JA; De los Toyos JR; Barneo L
    Histol Histopathol; 2015 Jan; 30(1):87-93. PubMed ID: 25005174
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Different transendothelial migration behaviour pattern of blood monocytes derived from patients with benign and malignant diseases of the breast.
    Gebhard B; Gnant M; Schütz G; Roka S; Weigel G; Kandioler D; Taucher S; Grünberger T; Roth E; Jakesz R; Spittler A
    Anticancer Res; 2000; 20(6B):4599-604. PubMed ID: 11205309
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Circulating antibodies against the breast tumor marker GCDFP-15/gp17 in mammary carcinoma patients and in patients carrying benign breast conditions.
    Pasquinelli R; Barba P; Capasso I; D'Aiuto M; D'Aiuto G; Anzisi AM; De Berardinis P; Guardiola J
    Int J Cancer; 1999 Dec; 84(6):568-72. PubMed ID: 10567900
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The LAI test in specific immune-reactivity studies of fibrocytic breast disease.
    Cavallini G; Berti G
    Tumori; 1982 Aug; 68(4):291-4. PubMed ID: 7147353
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast.
    Yoshida T; Matsumoto E; Hanamura N; Kalembeyi I; Katsuta K; Ishihara A; Sakakura T
    J Pathol; 1997 Aug; 182(4):421-8. PubMed ID: 9306963
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of telomere length and telomerase activation between breast fibroadenoma and infiltrating ductal carcinoma in Malaysian women.
    Looi LM; Cheah PL; Ng MH; Yip CH; Mun KS; Rahman NA
    Asian Pac J Cancer Prev; 2010; 11(3):713-6. PubMed ID: 21039041
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of c-erbB-2 oncogene and p53 tumor suppressor gene in benign and malignant breast tissue: correlation with proliferative activity and prognostic index.
    Alexiev BA; Bassarova AV; Popovska SL; Popov AA; Christov CZ
    Gen Diagn Pathol; 1997 Jun; 142(5-6):271-9. PubMed ID: 9228249
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Spectrum of carcinoembryonic antigen immunoreactivity from isolated ductal hyperplasias to atypical hyperplasias associated with infiltrating ductal breast cancer.
    Schmitt FC; Andrade L
    J Clin Pathol; 1995 Jan; 48(1):53-6. PubMed ID: 7706519
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Glycosaminoglycan (GAG) content and GAG electropherogram pattern of breast tumors and chronic fibrous mastopathy].
    Sehrt B; Mangakis N
    Arch Geschwulstforsch; 1982; 52(6):459-68. PubMed ID: 7159184
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunoglobulin levels in breast cyst fluid: apparent connection with intracystic transcortin (CBG) binding activity.
    Agrimonti F; Cavallo R; Frairia R; Violino PL; Borretta G; Angeli A
    Boll Ist Sieroter Milan; 1982 Mar; 61(1):44-50. PubMed ID: 6812601
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Telomerase activity, and tissue polypeptide specific antigen (TPS) in Egyptian breast cancer patients.
    Kassim SK; Fawzy H; El Rassad MM; Khalil FK; Khalifa A
    Clin Biochem; 2001 Sep; 34(6):499-504. PubMed ID: 11676980
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Cystic hypersecretory carcinoma with microinvasive carcinoma and cystic hypersecretory hyperplasia of breast: report of a case].
    Chen DB; Kan X
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):54-5. PubMed ID: 20388402
    [No Abstract]   [Full Text] [Related]  

  • 73. Behaviour of estrogen receptor, histological correlation, and clinical outcome in patients with benign breast disorders.
    Khanna AK; Tapodar JK; Khanna HD; Khanna S; Khanna A
    Eur J Surg; 2002; 168(11):631-4. PubMed ID: 12699101
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Monoclonal antibody B72.3 in benign breast lesions.
    Soomro S; Shousha S
    J Clin Pathol; 1990 Dec; 43(12):1026-8. PubMed ID: 2266175
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Assessment of homogeneity in polypeptide expression in breast carcinomas shows widely variable expression in highly malignant tumors.
    Franzén B; Auer G; Alaiya AA; Eriksson E; Uryu K; Hirano T; Okuzawa K; Kato H; Linder S
    Int J Cancer; 1996 Oct; 69(5):408-14. PubMed ID: 8900376
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis.
    Madrid FF; Maroun MC; Olivero OA; Long M; Stark A; Grossman LI; Binder W; Dong J; Burke M; Nathanson SD; Zarbo R; Chitale D; Zeballos-Chávez R; Peebles C
    BMC Cancer; 2015 May; 15():407. PubMed ID: 25975273
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Loss of fibronectin in human breast cancer.
    Labat-Robert J; Birembaut P; Adnet JJ; Mercantini F; Robert L
    Cell Biol Int Rep; 1980 Jun; 4(6):609-16. PubMed ID: 6249503
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Radiological case of the month. Benign simple cyst, benign fibroadenoma & malignant carcinoma of the breast.
    Anderson NK; Harshfield D
    J Ark Med Soc; 1996 Sep; 93(4):203-9. PubMed ID: 8840751
    [No Abstract]   [Full Text] [Related]  

  • 79. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions.
    Weinstat-Saslow D; Merino MJ; Manrow RE; Lawrence JA; Bluth RF; Wittenbel KD; Simpson JF; Page DL; Steeg PS
    Nat Med; 1995 Dec; 1(12):1257-60. PubMed ID: 7489405
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression of Ki-67 and p27(Kip1) in fine-needle aspirates from breast carcinoma and benign breast diseases.
    Ramljak V; Sučić M; Vrdoljak DV; Borojević N
    Diagn Cytopathol; 2011 May; 39(5):333-40. PubMed ID: 21488176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.